The impact of lymph node ratio in patients with stage IIIC endometrial carcinoma

dc.contributor.authorOnal, C.
dc.contributor.authorSari, S. Yuce
dc.contributor.authorYavas, G.
dc.contributor.authorGuler, O. C.
dc.contributor.authorYigit, E.
dc.contributor.authorOymak, E.
dc.contributor.authorGultekin, M.
dc.contributor.authorYildiz, F.
dc.date.accessioned2022-06-14T12:47:10Z
dc.date.available2022-06-14T12:47:10Z
dc.date.issued2021
dc.identifier.endpageS346en_US
dc.identifier.issn0167-8140en_US
dc.identifier.startpageS345en_US
dc.identifier.urihttp://hdl.handle.net/11727/7029
dc.identifier.volume161en_US
dc.identifier.wos000709667201029en_US
dc.language.isoengen_US
dc.relation.journalRADIOTHERAPY AND ONCOLOGYen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleThe impact of lymph node ratio in patients with stage IIIC endometrial carcinomaen_US
dc.typeconferenceObjecten_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: